- Home
- BMRA vs POAI Comparison
BMRA vs POAI Comparison
Compare BMRA & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- POAI
- Stock Information
- Founded
- BMRA 1971
- POAI 2002
- Country
- BMRA United States
- POAI United States
- Employees
- BMRA N/A
- POAI N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- POAI Industrial Specialties
- Sector
- BMRA Health Care
- POAI Health Care
- Exchange
- BMRA Nasdaq
- POAI Nasdaq
- Market Cap
- BMRA 8.2M
- POAI 7.8M
- IPO Year
- BMRA N/A
- POAI N/A
- Fundamental
- Price
- BMRA $2.98
- POAI $0.95
- Analyst Decision
- BMRA
- POAI Hold
- Analyst Count
- BMRA 0
- POAI 1
- Target Price
- BMRA N/A
- POAI N/A
- AVG Volume (30 Days)
- BMRA 470.5K
- POAI 124.3K
- Earning Date
- BMRA 10-14-2025
- POAI 11-11-2025
- Dividend Yield
- BMRA N/A
- POAI N/A
- EPS Growth
- BMRA N/A
- POAI N/A
- EPS
- BMRA N/A
- POAI N/A
- Revenue
- BMRA $5,311,000.00
- POAI $1,664,696.00
- Revenue This Year
- BMRA N/A
- POAI $486.27
- Revenue Next Year
- BMRA N/A
- POAI $65.50
- P/E Ratio
- BMRA N/A
- POAI N/A
- Revenue Growth
- BMRA N/A
- POAI 71.65
- 52 Week Low
- BMRA $2.08
- POAI $0.55
- 52 Week High
- BMRA $10.16
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- BMRA 45.65
- POAI 58.00
- Support Level
- BMRA $2.74
- POAI $0.90
- Resistance Level
- BMRA $3.08
- POAI $1.08
- Average True Range (ATR)
- BMRA 0.23
- POAI 0.07
- MACD
- BMRA -0.01
- POAI 0.00
- Stochastic Oscillator
- BMRA 45.92
- POAI 43.48
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.